Top healthcare stocks: ABBV, UNH, LLY, PFE & DHR to explore in March

Be the First to Comment Read

Top healthcare stocks: ABBV, UNH, LLY, PFE & DHR to explore in March

Follow us on Google News:
 Top healthcare stocks: ABBV, UNH, LLY, PFE & DHR to explore in March
Image source: janews,Shutterstock

Highlights

  • AbbVie Inc. (NYSE: ABBV) revenue surged over 7% YoY in Q4, FY21.

  • Pfizer, Inc. (NYSE: PFE) revenue jumped 105% YoY in the fourth quarter of fiscal 2021.

  • Eli Lilly and Co. (NYSE: LLY) fiscal 2021 revenue was up 15% YoY.

The healthcare stocks saw robust gains driven by the medical technology segment lately. Of some US$8 trillion spent on the global healthcare sector, nearly half of it was spent in the US. The amount is expected to increase significantly in the coming years.

Here we explore the top healthcare companies worth exploring.

Also Read: Why is UFC supporter Marshall Rogan (MRI) crypto rising?

UnitedHealth Group Incorporated (NYSE: UNH)

UnitedHealth is a diversified healthcare and insurance company based in Minnetonka, Minnesota. It has four business segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx.

The shares of the company traded at US$486.00 at 1:04 pm ET on March 2, up 2.05% from their closing price of March 1. Its stock value increased by 42.32% over the past 12 months.

The firm has a market cap of US$457.33 billion, a P/E ratio of 26.88, and a forward one-year P/E ratio of 21.96. Its current yield is 1.22%, and its annualized dividend is US$5.80.

The 52-week highest and lowest stock prices were US$509.23 and US$332.67, respectively. Its trading volume was 2,917,576 on March 1.

The company reported revenue of US$73.74 billion in Q4, FY21, while its net earnings came in at US$4.19 billion, or US$4.26 per share. For fiscal 2021, the company's total revenue was US$287.59 billion.

Also Read: Why is ZimVie Inc (ZIMV) stock trending?

Dividend paying healthcare stocks to explore in 2022

Source: ©2022 Kalkine Media®

Also Read: Why is Origin Protocol (OGN) gaining attention?

AbbVie Inc. (NYSE: ABBV)

AbbVie Inc is a research-based biopharmaceutical firm based in Lake Bluff, Illinois. It focuses on researching, developing, and manufacturing medicines and therapies.

The stock of the company traded at US$151.04 at 1:09 pm ET on March 2, up 2.27% from its previous closing price. The ABBV stock rose 36.94% over the past 12 months.

The market cap of the company is US$267.06 billion, the P/E ratio is 23.41, and the forward one-year P/E ratio is 10.45. Its current yield is 3.82%, and its annualized dividend is US$5.64.

The stock saw the highest price of US$150.36 and the lowest price of US$102.05 in the last 52 weeks. Its share volume on March 1 was 7,489,868.

The company's net revenue rose 7.4% YoY to US$14.88 billion in Q4, FY21, while its net income came in at US$4.04 billion, or US$2.26 per diluted share. For fiscal 2021, the company's revenue surged 22.7% YoY to US$56.19 billion.

Also Read: What is MetisDAO (METIS) crypto? Know price and performance

Pfizer, Inc. (NYSE: PFE)

Pfizer is one of the leading pharmaceutical and biotechnology firms that discover, develop, and manufacture biopharmaceutical products like medicines and vaccines. It is based in New York.

The shares of the company traded at US$47.775 at 1:15 pm ET on March 2, up 4.43% from their closing price of March 1. Its stock value soared 36.53% over the past 12 months.

The firm has a market cap of US$267.75 billion, a P/E ratio of 12.37, and a forward one-year P/E ratio of 6.55. Its current yield is 3.41%, and its annualized dividend is US$1.60.

The 52-week highest and lowest stock prices were US$61.71 and US$33.44, respectively. Its trading volume was 29,854,510 on March 1.

The company's revenue increased by 105% YoY to US$23.83 billion in Q4, FY21, while its net income came in at US$3.39 billion, or US$0.59 per diluted share. For fiscal 2021, the company's revenue jumped 95% YoY to US$81.28 billion.

Also Read: Why is Chiliz (CHZ) crypto gaining attention?

Eli Lilly and Co. (NYSE: LLY)

Eli Lilly is a pharmaceutical and drug manufacturing firm that provides its products and services in various markets globally. It is based in Indianapolis, Indiana.

The stock of the company traded at US$254.47 at 1:18 pm ET on March 2, up 1.99% from its previous closing price. The LLY stock jumped 22.22% over the past 12 months.

The market cap of the company is US$242.27 billion, the P/E ratio is 41.43, and the forward one-year P/E ratio is 28.88. Its current yield is 1.57%, and its annualized dividend is US$3.92.

The stock saw the highest price of US$283.90 and the lowest price of US$178.58 in the last 52 weeks. Its share volume on March 1 was 2,873,291.

The company's revenue soared 8% YoY to US$7.99 billion in Q4, FY21, while its net income came in at US$1.72 billion, or US$1.90 per diluted share. Its revenue for fiscal 2021 was US$28.31 billion, up 15% YoY.

Also Read: What is Ankr (ANKR) crypto?

Healthcare stocks: UNH, ABBV, PFE, LLY, DHR

Also Read: From COIN to PYPL: Crypto-focused stocks to explore in March

Danaher Corporation (NYSE: DHR)

Danaher is a diversified conglomerate firm based in Washington, D.C. It focuses on designing, developing, and manufacturing a range of products like medical, industrial, commercial products, and other related solutions.

The shares of the company traded at US$274.785 at 1:23 pm ET on March 2, up 1.01% from their closing price of March 1. Its stock value ticked up 21.39% over the past 12 months.

The firm has a market cap of US$196.22 billion, a P/E ratio of 31.82, and a forward one-year P/E ratio of 26.13. Its current yield is 0.31%, and its annualized dividend is US$1.00.

The 52-week highest and lowest stock prices were US$333.96 and US$211.22, respectively. Its trading volume was 2,000,103 on March 1.

The company's total sales were US$8.14 billion in Q4, FY21, while its net earnings came in at US$1.78 billion, or US$2.39 per diluted share. Its sales for fiscal 2021 was US$29.45 billion.

Also Read: Is Crypto Comeback Pro legit or a scam?

Bottom line:

The S&P 500 healthcare index surged 13.34% in the past 12 months while declining 8.49% YTD.

Various investors have shown interest in long-term holds in the sector. However, the overall financial market besides the healthcare sector has slumped in recent weeks due to various elevated macroeconomic and geopolitical tensions.

Disclaimer

Featured Articles